Treatment of Liver Failures and Severe Constipation and Treatment of Stomach Ulcer (Kazhwa)
Innovator:
Mr. Khebat Khedri
Company: Zaribar Marivan Drug Health Company
Owners of the innovation:
Treatment of Liver Failures and Severe Constipation and Treatment of Stomach Ulcer (Kazhwa)
Acknowledgment: Congratulations on being one of the pioneer innovators who have obtained the IFIA Innovation Standard certificate (IIS).
Following your inquiry for an IIS certification, the jury board evaluated your application according to the criteria. And after the assessment and examinations, your innovation was granted with IFIA Innovation Standard Grade B.
IFIA hopes that by having this certification, you will take an essential step in the commercialization of your innovation. Also, by entering international markets, you can contribute to the realization of the global slogan: Generating wealth through innovative knowledge.
The Summary of Innovation:
The interference Flavonoids in the liver cells, there is a significant effect on the activity of the limiting enzyme of the cholesterol synthesis pathway, namely HMG-Coareductase. Flavonoids in the liver cells resulting in the reduction of the compound of labeled acetate (1-14C) with fatty acid.
Why is this innovation eligible to receive the IIS certification?
Since people consume junk food more than ever in today’s world, liver disorders, including liver failure, liver cancer, and severe fatty liver, can be around the corner for any of us. Therefore, this innovative herbal medicine is created to treat liver diseases and all types of hepatitis. Moreover, the interference of some active enzymes has resulted in a significant decrease in VLDL triglycerides. So, by obtaining this certificate, the global qualification of this medicine can aid all the people dealing with liver disorders and help them overcome their disease.